Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation release_4ofseerc45hwhoutecw3fvzswm

by Ciprian Tomuleasa, Florin Zaharie, Roxana-Maria Cojocneanu-Petric, Mihai Muresan, Ioana Frinc, Delia Dima, Bobe Petrushev, Alina Tanase, Cristian Berce, Mariana Chitic, Ioana Berindan-Negoe, Valentina Pileczki (+1 others)

References

NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 7 of 7 references (in 145ms)
[1]

via fatcat-pubmed
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
Jennifer Wheler, Roman Yelensky, Gerald Falchook, Kevin B Kim, Patrick Hwu, Apostolia M Tsimberidou, Philip J Stephens, David Hong (+ more)
2015   BMC Cancer
doi:10.1186/s12885-015-1029-z  pmcid:PMC4340232  pmid:25886620 
web.archive.org [PDF]
[2]

via fatcat-pubmed
Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma
Calvin Yu-Chian Chen, Hsin-Chieh Tang
2015   International Journal of Nanomedicine
doi:10.2147/ijn.s80150  pmcid:PMC4412490  pmid:25960652 
web.archive.org [PDF]
[3]

via fatcat-pubmed
Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
Hsin-Chieh Tang, Calvin Yu-Chian Chen
2014   BioMed Research International
doi:10.1155/2014/798742  pmcid:PMC4090515  pmid:25045703 
web.archive.org [PDF]
[4]

via fatcat-pubmed
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia
E. Tiacci, G. Schiavoni, M. P. Martelli, E. Boveri, R. Pacini, A. Tabarrini, S. Zibellini, A. Santi (+ more)
2013   Haematologica
doi:10.3324/haematol.2012.078071  pmcid:PMC3659996  pmid:23349307 
web.archive.org [PDF]
[5]

via fatcat-pubmed
Resistance to RAF Inhibitors Revisited
Edward Hartsough, Yongping Shao, Andrew E. Aplin
2014   Journal of Investigative Dermatology
doi:10.1038/jid.2013.358  pmcid:PMC3947111  pmid:24108405 
web.archive.org [PDF]
[6]

via fatcat-pubmed
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity
V. Pettirossi, A. Santi, E. Imperi, G. Russo, A. Pucciarini, B. Bigerna, G. Schiavoni, E. Fortini (+ more)
2014   Blood
doi:10.1182/blood-2014-10-603100  pmcid:PMC4366655  pmid:25480661 
web.archive.org [PDF]
[7]

via fatcat-pubmed
Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
Catherine Louise Penman, Claire Faulkner, Stephen P. Lowis, Kathreena M. Kurian
2015   Frontiers in Oncology
doi:10.3389/fonc.2015.00054  pmcid:PMC4347423  pmid:25785246 
web.archive.org [PDF]